Home
/
Records
/
483
/
Brio Pharmaceuticals Inc

483

•Brio Pharmaceuticals Inc•July 11, 2019

FDA 483 - Brio Pharmaceuticals Inc - July 11, 2019

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Record Details

This 483 record concerns Brio Pharmaceuticals Inc, with an inspection on July 11, 2019, issued by the Dallas District Office, covering drugs.

Company: Brio Pharmaceuticals Inc
Inspection Date: July 11, 2019
Product Type: Drugs
Office: Dallas District Office
Person: Camerson E. Moore (Microbiologist)

Open in Dashboard

ID · d9ede2da-3c47-4177-bc0f-09199aee50e6

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

[email protected]

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA 483 - Brio Pharmaceuticals Inc - July 11, 2019 | Global Key Solutions